Stockscreener 앱 받기
1.43
7.14%
-0.11
시간 외 거래:
1.43
Rafael Holdings Inc 주식(RFL)의 최신 뉴스
Rafael announces revised subscription rights in connection with offering - TipRanks
Ichnos Glenmark Innovation (IGI) Receives U.S. FDA Fast Track Designation for ISB 2001 for Relapsed/Refractory Multiple Myeloma - The Manila Times
Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously ... - Bluefield Daily Telegraph
Rafael Holdings Launches $25M Rights Offering: Key Dates and Terms Investors Must Know - Stock Titan
Geode Capital Management LLC Purchases 26,493 Shares of Rafael Holdings, Inc. (NYSE:RFL) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Metric Deep Dive: Understanding Rafael Holdings Inc (RFL) Through its Ratios - DWinneX
Tronox Holdings plc: Navigating Market Fluctuations with a 857.28M Market Cap - investchronicle.com
Rafael Holdings Inc (RFL) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™ - The Manila Times
Sonoco Reports First Quarter 2025 Results - The Manila Times
Rafael Holdings Secures Future: $25M Rights Offering Powers Critical Phase 3 Drug Launch Plans - Stock Titan
Rafael Holdings Strengthens its Focus on the Development of Trappsol Cyclo and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role - marketscreener.com
Rafael Holdings CEO Resignation Announced - TipRanks
Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role - The Manila Times
Rafael Holdings Announces Leadership Transition Following Merger with Cyclo Therapeutics and Full Enrollment of TransportNPC™ Phase 3 Trial for Niemann-Pick Disease Treatment - Nasdaq
Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces - Bluefield Daily Telegraph
Rafael Holdings Pivots to Breakthrough Rare Disease Drug Development as Leadership Changes - Stock Titan
SEC Form S-3 filed by Ekso Bionics Holdings Inc. - Quantisnow
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CYTH, VGR, TTNP on Behalf of Shareholders - ACCESS Newswire
General Atomics Partners With Rafael to Build Precision-Guided Missile for U.S. Defense Customers - Yahoo Finance
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GVP, AFBI, RFL, MNTX on Behalf of Shareholders - ACCESS Newswire
Autodesk announces Betsy Rafael to step down from Board of Directors - Yahoo Finance
Rafael Holdings finalizes merger with Cyclo Therapeutics By Investing.com - Investing.com South Africa
Rafael Closes Merger With Cyclo Therapeutics - MarketScreener
Rafael Holdings Completes Merger With Cyclo Therapeutics Following Shareholder Approvals - MarketScreener
Cyclo Therapeutics Merges with Rafael Holdings - TipRanks
Does Rafael Holdings (NYSE:RFL) Have A Healthy Balance Sheet? - simplywall.st
Rafael Holdings Completes Merger with Cyclo Therapeutics - TipRanks
Volatility Alert: 10 Stocks Showing High IV Percentile - The Globe and Mail
Rafael Holdings finalizes merger with Cyclo Therapeutics - Investing.com
Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals - GlobeNewswire
Major Pharma Merger: Rafael Holdings Gains Phase 3 Rare Disease Asset in Strategic Deal - Stock Titan
I Would Not Short Tesla Stock at Current Valuations - The Globe and Mail
Rafael Holdings secures shareholder nod for Cyclo Therapeutics merger By Investing.com - Investing.com Australia
Can SoundHound AI Double? What the Fundamentals and Deals Reveal - The Globe and Mail
Rafael Holdings secures shareholder nod for Cyclo Therapeutics merger - Investing.com
Cyclo Therapeutics shareholders approve merger with Rafael Holdings - Investing.com
TPT Global Tech Set to Broadcast First MASL Professional Indoor Soccer Game on Its VuMe Live Super App - The Globe and Mail
March Madness: Flutter Stock Is a Solid Bet on Sustained Growth - The Globe and Mail
Bull markets have begun…outside the U.S. - The Globe and Mail
Q4 Earnings Highlights: Apogee (NASDAQ:APOG) Vs The Rest Of The Commercial Building Products Stocks - The Globe and Mail
Cyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL) - Business Wire
Rafael Holdings Reports Q2 Fiscal 2025 Results - TipRanks
Rafael Holdings Inc Reports Q2 2025 Earnings: EPS at -$0.19, Str - GuruFocus.com
Rafael Holdings, Inc. SEC 10-Q Report - TradingView
JAB Implements New Strategy and Team Structure - Business Wire
Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results - br.ADVFN.com
Rafael Holdings, Inc. Reports Financial Results and Anticipates Closure of Merger with Cyclo Therapeutics in Q3 - Nasdaq
Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results - GlobeNewswire Inc.
Full Stock Market News from 2025-03-13 - StockTitan
San Rafael medical robotics firm revenue dips nearly 2% in 2024 - North Bay Business Journal
Cyclo Therapeutics secures $2.5 million in funding By Investing.com - Investing.com Australia
Cyclo Therapeutics Inc Issues $2.5 Million Convertible Promissory Note To Rafael Holdings - Marketscreener.com
Cyclo Therapeutics secures $2.5 million in funding - Investing.com India
6.24%
0.24%
자본화:
|
볼륨(24시간):